In the last week, the market has been flat, but it is up 21% over the past year with earnings expected to grow by 18% per annum over the next few years. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.
| Name | Insider Ownership | Earnings Growth |
| XCHG (XCH) | 39.7% | 102.2% |
| Uxin (UXIN) | 34.3% | 69.4% |
| Upstart Holdings (UPST) | 14.1% | 60% |
| KVH Industries (KVHI) | 16.2% | 146.1% |
| Karman Holdings (KRMN) | 15.6% | 52.6% |
| IREN (IREN) | 13.6% | 38.8% |
| ERock (EROC) | 20.1% | 56.3% |
| Corcept Therapeutics (CORT) | 10.9% | 47.8% |
| Cerebras Systems (CBRS) | 10.9% | 73.7% |
| AppLovin (APP) | 23.2% | 21.7% |
We're going to check out a few of the best picks from our screener tool.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Bank First Corporation operates as a holding company for Bank First, N.A., with a market cap of $1.63 billion.
Operations: The company generates revenue primarily from its banking operations, amounting to $193.62 million.
Insider Ownership: 10.3%
Earnings Growth Forecast: 40.7% p.a.
Bank First demonstrates strong growth potential with forecasted earnings growth of 40.7% annually and revenue growth of 32.4%, outpacing the broader US market. Recent board changes, including the election of three new directors, reflect strategic leadership adjustments. The company has initiated a share repurchase program worth up to US$60 million, indicating confidence in its financial health. Despite limited insider trading activity, insider ownership remains significant, aligning management interests with shareholders'. Earnings per share slightly declined from US$1.82 to US$1.78 year-over-year in Q1 2026.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Prenetics Global Limited is a consumer health sciences company operating in the United States and Hong Kong, with a market cap of $357.44 million.
Operations: Revenue segments for the company include consumer health sciences operations in the United States and Hong Kong.
Insider Ownership: 25.6%
Earnings Growth Forecast: 84.1% p.a.
Prenetics Global is trading significantly below its estimated fair value, with analysts anticipating a 74.7% price rise. The company forecasts robust revenue growth of 48.4% annually, surpassing US market averages, and aims for profitability within three years. Recent strategic moves include raising full-year revenue guidance to US$190-210 million and strengthening leadership with key appointments. Prenetics also secured a partnership with Inter Miami CF, enhancing brand visibility and global reach through sports marketing initiatives.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Live Oak Bancshares, Inc. is a bank holding company for Live Oak Banking Company, offering a range of banking products and services in the United States, with a market cap of approximately $1.92 billion.
Operations: The company generates revenue primarily through its banking platform for small businesses, amounting to $512.21 million.
Insider Ownership: 22.2%
Earnings Growth Forecast: 26.8% p.a.
Live Oak Bancshares is experiencing substantial growth, with earnings expected to rise 26.8% annually, outpacing the US market. Revenue is forecasted to grow at 20.8% per year, surpassing market averages. Despite a high level of bad loans at 4.2%, insider ownership remains strong with more shares bought than sold recently. The company trades at a significant discount to its estimated fair value and has undergone recent executive changes to strengthen its financial leadership team.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com